GORMAN KEVIN CHARLES bought NBIX
August 7, 2025 · Form 4 insider transaction
GORMAN KEVIN CHARLES bought 106,322 shares of Neurocrine Biosciences, Inc. at $35.99 per share, a transaction worth $3.83M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
106,322
Price
$35.99
Total value
$3.83M
InsiderGORMAN KEVIN CHARLES
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 7, 2025
Filing dateAugust 11, 2025
Shares owned after620,918
OwnershipDirect
10b5-1 planNo
AmendedNo